Korean J Pediatr.
2019 Nov;62(11):405-409. 10.3345/kjp.2019.00668.
Evaluation of drug interventions for the treatment of sleep disorders in children with autism spectrum disorders: a systematic review
- Affiliations
-
- 1Pediatric Developmental Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
- 2Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran. s.ataei@umsha.ac.ir
- 3Social Determinants of Health Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
- KMID: 2465640
- DOI: http://doi.org/10.3345/kjp.2019.00668
Abstract
- A structured review study of drug interventions on sleep disorders in patients with autism spectrum disorders (ASD) has not been published to date. This systematic review aimed to investigate drug interventions for the treatment of sleep disorders in children with ASD. The Web of Science, PubMed, and Scopus databases were searched until March 2019. Study quality was assessed using the Delphi checklist. Due to the heterogeneity of the findings, a meta-analysis was not possible. Drug interventions for the treatment of sleep disorders in patients with ASD included melatonin, atomoxetine, and risperidone. Atomoxetine had no effect on sleep disorders in patients with ASD. A total of 10 studies were reviewed. Melatonin appears to be useful for the treatment of sleep problems in patients with ASD, but further studies are needed to determine the effects of other drugs.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Psychosocial Treatments for Children with Autism Spectrum Disorder
- Sleep Problems in Autism Spectrum Disorder
- An update on the cause and treatment of sleep disturbance in children and adolescents with autism spectrum disorder
- Prenatal Topiramate Exposure and Risk of Neurodevelopmental Disorders: A Systematic Review
- Aripiprazole Improved Obsessive Compulsive Symptoms in Asperger's Disorder
